Dipeptidyl peptidase-4 inhibitor reduces infarct size and preserves cardiac function via mitochondrial protection in ischaemia-reperfusion rat heart
Aim: We hypothesized that dipeptidyl peptidase (DPP)-4 inhibitor (vildagliptin) reduces fatal arrhythmias, cardiac dysfunction and infarct size caused by ischaemiareperfusion (I/R) injury via its attenuation of cardiac mitochondrial dysfunction. Methods: In total, 26 rats were randomized to receive...
Saved in:
Main Authors: | Kroekkiat Chinda, Jantira Sanit, Siriporn Chattipakorn, Nipon Chattipakorn |
---|---|
Format: | Journal |
Published: |
2018
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84894488315&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/45131 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Dipeptidyl peptidase-4 inhibitor reduces infarct size and preserves cardiac function via mitochondrial protection in ischaemia-reperfusion rat heart
by: Kroekkiat Chinda, et al.
Published: (2018) -
Dipeptidyl peptidase-4 inhibitor reduces infarct size and preserves cardiac function via mitochondrial protection in ischaemia-reperfusion rat heart
by: Chinda K., et al.
Published: (2014) -
Dipeptidyl peptidase-4 inhibitor reduces infarct size and preserves cardiac function via mitochondrial protection in ischaemia-reperfusion rat heart
by: Chinda K., et al.
Published: (2014) -
Effect of rosiglitazone on cardiac electrophysiology, infarct size and mitochondrial function in ischaemia and reperfusion of swine and rat heart
by: Siripong Palee, et al.
Published: (2018) -
Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia-reperfusion injury
by: Kroekkiat Chinda, et al.
Published: (2018)